{"preqs":"PHA3011 and one of PHA3021, BMS3021 or BMS3031","creditPoints":6,"rules":[{"startDate":"1/01/2013","status":"ACTIVE","ruleSummary":"TRANS","ruleString":"Unit was previously coded {PHA3042%}","endDate":""},{"startDate":"1/01/2013","status":"ACTIVE","ruleSummary":"PREREQ-IW","ruleString":"(Must have passed an (I/W) unit in {PHA3011} and  Must have passed an (I/W) unit in {BMS3021, BMS3031, PHA3021})","endDate":""}],"locationAndTime":[{"location":"Clayton","time":["Second semester 2017 (Day)"]}],"enjoyScore":4.766666667,"learnScore":5,"learnResponse":1,"proh":"","scaBand":2,"unitName":"Modern drug development","description":"Modern drug development will provide the student with an appreciation of the process of discovery, testing, approval and marketing of new drugs. This will include the diseases most likely to be targeted by pharmaceutical companies for drug development; the technical issues underlying drug discovery; the role of genomics in identifying novel targets; rational drug design; the importance of screens including molecular models and high throughput screening; disease models; case studies illustrating the successful development of drugs. Career opportunities in all aspects of drug development will be highlighted.","enjoyResponse":22,"faculty":"Faculty of Science","unitCode":"PHA3042","eftsl":0.125}